Search Within

Thoracic Oncology

  1. "Jedd Wolchok"
Formats
  1. Journal Article (37)
  2. Meeting Abstract (28)
  3. Research Letter (1)
  4. Review (1)
Groups
  1. Department of Medicine (67)
  2. GSK Faculty (67)
  3. Melanoma and Immunotherapeutics Service (67)
  4. Solid Tumor Oncology Division (67)
  5. Sloan Kettering Institute Postdocs (26)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (25)

More Groups

People
  1. Jedd Wolchok (67)
  2. Matthew Hellmann (53)
  3. Taha Merghoub (37)
  4. Jamie Chaft (18)
  5. Michael Postow (16)
  6. Andrew Chow (14)

More People

Years
  1. 2023 (3)
  2. 2022 (9)
  3. 2021 (6)
  4. 2020 (7)
  5. 2019 (8)
  6. 2018 (12)

More Years

Publications
  1. Cancer Research (9)
  2. Journal for ImmunoTherapy of Cancer (9)
  3. Journal of Clinical Oncology (7)
  4. Cancer Cell (5)
  5. Annals of Oncology (4)
  6. Nature (3)

More Publications

Publishers
  1. American Association for Cancer Research (14)
  2. Biomed Central Ltd (9)
  3. Cell Press (8)
  4. American Society of Clinical Oncology (7)
  5. Nature Publishing Group (7)
  6. Elsevier Inc. (5)

More Publishers

Results (67)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A pilot trial of autologous tumor infiltrating lymphocytes (lifileucel, LN-144) for patients with asymptomatic melanoma brain metastases
    Meeting Abstract

    Betof Warner, A.; Postow, M. A.; Panageas, K.; Smithy, J. W.; Schoenfeld, A. J.; Wolchok, J. D.; Shoushtari, A. N.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Lineage tracing reveals clonal progenitors and long-term persistence of tumor-specific T cells during immune checkpoint blockade
    Journal Article

    Pai, J. A.; Hellmann, M. D.; Sauter, J. L.; Mattar, M.; Rizvi, H.; Woo, H. J.; Shah, N.; Nguyen, E. M.; Uddin, F. Z.; Quintanal-Villalonga, A.; more...
    Cancer Cell (2023)

    Fulltext@MSK | Save
  • The ectonucleotidase CD39 identifies tumor-reactive CD8(+) T cells predictive of immune checkpoint blockade efficacy in human lung cancer
    Journal Article

    Chow, A.; Uddin, F. Z.; Liu, M.; Dobrin, A.; Nabet, B. Y.; Mangarin, L.; Lavin, Y.; Rizvi, H.; Tischfield, S. E.; Quintanal-Villalonga, A.; more...
    Immunity (2023)

    Fulltext@MSK | Save
  • Immunogenic landscape and therapeutic targeting of mutant NRAS "public" neoantigens
    Meeting Abstract

    Etxeberria, I.; Banks, L.; Chandran, S.; Correa, A.; Novak, B.; Fleischman, J.; Drilon, A.; Wolchok, J.; Merghoub, T.; Klebanoff, C.
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Integrative genomics of checkpoint blockade response in advanced non-small cell lung cancer
    Meeting Abstract

    Ravi, A.; Gainor, J.; Arniella, M.; Stewart, C.; Freeman, S.; Awad, M. M.; Forde, P.; Anagnostou, V.; Henick, B.; Riess, J. W.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Activating canonical p53 functions in tumor-associated macrophages improves immune checkpoint blockade efficacy
    Meeting Abstract

    Ghosh, A.; Michel, J.; Venkatesh, D.; Mezzadra, R.; Dong, L.; Samaan, F.; Gomez, R.; Suek, N.; Holland, A.; Ho, Y. J.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Clinical characteristics and molecular features of non-small cell lung cancers (NSCLCs) following disease progression on immune checkpoint inhibitors (ICIs)
    Meeting Abstract

    Gainor, J. F.; Ravi, A.; Awad, M. M.; Holton, M.; Arniella, M.; Stewart, C.; Freeman, S.; Leshchiner, I.; Chow, A.; Henick, B. S.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Clinical implications of T cell exhaustion for cancer immunotherapy
    Review

    Chow, A.; Perica, K.; Klebanoff, C. A.; Wolchok, J. D.
    Nature Reviews Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Increased p53 expression induced by APR-246 reprograms tumor-associated macrophages to augment immune checkpoint blockade
    Journal Article

    Ghosh, A.; Michels, J.; Mezzadra, R.; Venkatesh, D.; Dong, L.; Gomez, R.; Samaan, F.; Ho, Y. J.; Campesato, L. F.; Mangarin, L.; more...
    Journal of Clinical Investigation (2022)

    Fulltext@MSK | Save
  • Fundamental immune–oncogenicity trade-offs define driver mutation fitness
    Journal Article

    Hoyos, D.; Zappasodi, R.; Schulze, I.; Sethna, Z.; de Andrade, K. C.; Bajorin, D. F.; Bandlamudi, C.; Callahan, M. K.; Funt, S. A.; Hadrup, S. R.; more...
    Nature (2022)

    Fulltext@MSK | Save